Drugs / hypertonic saline
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02760719 | Dec 2015 → Jul 2019 | bronchiolitis | University Medical Centre Ljubljana | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | hypertonic saline | “In recent years some studies have suggested that nebulised hypertonic saline, which improve airway hygiene, may influence the course of the illness and reduce the duration of...” NCT02760719 ↗ |
| Known as | hypertonic saline solution | “This study evaluates the effectiveness of nebulized 3% hypertonic saline solution with salbutamol in the treatment of children under 2 years, hospitalised for acute viral bronchiolitis.” NCT02760719 ↗ |
| Route | Inhaled | “4 ml of nebulized 3 % hypertonic saline” NCT02760719 ↗ |